omniture
康希诺生物股份公司 Consino Biological Inc

Latest News

CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing

TIANJIN, China, May 19, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HK...

2022-05-19 23:28 3697

CanSinoBIO Rebrands to Reflect Commitment to Life Sciences Research

TIANJIN, China, April 25, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the Company...

2022-04-25 08:00 2502

CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China

TIANJIN, April 4, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the Company") (SSE:...

2022-04-04 08:30 5121

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in Malaysia and Indonesia

TIANJIN, China, March 22, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, ...

2022-03-22 21:32 2216

Latest Study Shows Advantages of CanSinoBIO's Convidecia™ as Heterologous Booster against Omicron Variant

TIANJIN, China, March 14, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, ...

2022-03-14 08:00 2745

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China

TIANJIN, China, Feb. 21, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, H...

2022-02-21 08:05 3058

Latest Study Shows Encouraging Results of CanSinoBIO's Inhaled COVID-19 Vaccine as Heterologous Booster

TIANJIN, China, Jan. 11, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, H...

2022-01-11 15:15 2323

CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China

TIANJIN, China, Jan. 9, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HK...

2022-01-09 10:09 3800

Convidecia™ Phase III Results Published in The Lancet

* 96.0% effective against severe disease 14 days post-vaccination for population aged 18 and abov...

2021-12-24 15:28 6324

CanSinoBIO Receives European GMP Certification for its COVID-19 Vaccine Convidecia™

* A major step for introducing Convidecia™ to more countries and people in need for protection ...

2021-05-24 17:00 5993

CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Chile

* Marks vaccine's first approval in South America, following Mexico, Pakistan, China and Hungary ...

2021-04-08 21:17 7219

CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Hungary

* Marks vaccine's first approval by an European Union member state, following Mexico, Pakistan an...

2021-03-23 00:43 3837

CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Dual Listing Vaccine Company

SHANGHAI, Aug. 13, 2020 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SHSE: 688185, HKEX:0...

2020-08-13 10:00 10875